MA56506A - Promédicamentà base de succinate, compositions contenant le promédicament de succinate et utilisations associées - Google Patents

Promédicamentà base de succinate, compositions contenant le promédicament de succinate et utilisations associées

Info

Publication number
MA56506A
MA56506A MA056506A MA56506A MA56506A MA 56506 A MA56506 A MA 56506A MA 056506 A MA056506 A MA 056506A MA 56506 A MA56506 A MA 56506A MA 56506 A MA56506 A MA 56506A
Authority
MA
Morocco
Prior art keywords
succinate prodrug
compositions containing
prodrug
succinate
compositions
Prior art date
Application number
MA056506A
Other languages
English (en)
French (fr)
Inventor
Mats Eskil Elmér
Mark Richard Farmery
Matthew Alan Gregory
Alvar Grönberg
Magnus Joakim Hansson
Steven James Moss
Lee Robert Webster
Original Assignee
Abliva Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abliva Ab filed Critical Abliva Ab
Publication of MA56506A publication Critical patent/MA56506A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/30—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Birds (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MA056506A 2019-06-19 2020-06-18 Promédicamentà base de succinate, compositions contenant le promédicament de succinate et utilisations associées MA56506A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201970383 2019-06-19
DKPA201970382 2019-06-19
DKPA201970384 2019-06-19

Publications (1)

Publication Number Publication Date
MA56506A true MA56506A (fr) 2022-04-27

Family

ID=71130953

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056506A MA56506A (fr) 2019-06-19 2020-06-18 Promédicamentà base de succinate, compositions contenant le promédicament de succinate et utilisations associées

Country Status (10)

Country Link
US (2) US11565998B2 (enExample)
EP (2) EP3986862B1 (enExample)
JP (2) JP7699551B2 (enExample)
KR (1) KR102871719B1 (enExample)
CN (1) CN113993842B (enExample)
CA (1) CA3143112A1 (enExample)
IL (1) IL288990B2 (enExample)
MA (1) MA56506A (enExample)
MX (1) MX2021015137A (enExample)
WO (1) WO2020254484A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL288990B2 (en) * 2019-06-19 2025-09-01 Abliva Ab Succinate drug meters, preparations containing the succinate drug meters and its uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612331D0 (en) 1996-06-13 1996-08-14 Leo Pharm Prod Ltd Chemical compounds
AUPR059400A0 (en) 2000-10-06 2000-11-02 Bar-Ilan University Formaldehyde-releasing prodrugs
PT3129016T (pt) 2014-04-08 2018-10-01 Neurovive Pharmaceutical Ab Compostos novos
CA2944575A1 (en) 2014-04-08 2015-10-15 Neurovive Pharmaceutical Ab Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to complex i-related impairment of mitochondrial oxidative phosphorylation
IL288990B2 (en) * 2019-06-19 2025-09-01 Abliva Ab Succinate drug meters, preparations containing the succinate drug meters and its uses

Also Published As

Publication number Publication date
MX2021015137A (es) 2022-01-18
US20230033294A1 (en) 2023-02-02
WO2020254484A1 (en) 2020-12-24
US20220162162A1 (en) 2022-05-26
EP4360708A2 (en) 2024-05-01
JP2025004155A (ja) 2025-01-14
EP3986862A1 (en) 2022-04-27
CN113993842A (zh) 2022-01-28
KR102871719B1 (ko) 2025-10-15
IL288990A (en) 2022-02-01
EP3986862C0 (en) 2024-01-24
US11565998B2 (en) 2023-01-31
CA3143112A1 (en) 2020-12-24
US12162824B2 (en) 2024-12-10
JP7699551B2 (ja) 2025-06-27
CN113993842B (zh) 2024-07-16
JP2022538009A (ja) 2022-08-31
KR20220024780A (ko) 2022-03-03
IL288990B2 (en) 2025-09-01
BR112021024510A2 (pt) 2022-01-18
EP3986862B1 (en) 2024-01-24
IL288990B1 (en) 2025-05-01
AU2020298031A1 (en) 2022-02-03
EP4360708A3 (en) 2024-12-25

Similar Documents

Publication Publication Date Title
CL2022000448A1 (es) Autoinyector (divisional solicitud no. 201903061)
MA51288A (fr) Analogues d'incrétine et leurs utilisations
UA45061S (uk) 1. футляр
EP3891149A4 (en) RET INHIBITOR, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
MA51287A (fr) Analogues d'incrétine et leurs utilisations
EP3434676A4 (en) SUBSTITUTED PYRROLOPYRIMIDINE-CDK INHIBITORS, PHARMACEUTICAL COMPOSITION THEREFOR AND USE THEREOF
EP3463277A4 (en) FORMULATIONS FOR SUBSTITUTED 3-PYRROLIDINES, COMPOSITIONS THEREFOR AND USES THEREOF
EP3481414A4 (en) FORMULATIONS OF ABALOARATIDE, TRANSDERMAL PLASTERS THEREOF AND USES THEREOF
MA49047A (fr) Composés inhibiteurs d'ask1 et utilisations associées
MA45857A (fr) Composés et compositions, et utilisations associées
MX2020011478A (es) Formas solidas de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il) -1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida y sus composiciones farmaceuticas y usos.
EP3846807A4 (en) IMIDAZOCHINOLINE COMPOUNDS AND USES THEREOF
EP3924323A4 (en) Tricyclodecane dimethanol compositions and uses thereof
MX2018008424A (es) Compuestos antiproliferativos y sus composiciones farmaceuticas y usos.
EP3880828A4 (en) PLANT VECTORS, COMPOSITIONS AND USES RELATED THERETO
EP3415502A4 (en) SUBSTITUTED HETEROARYL COMPOUND, COMPOSITION AND APPLICATION THEREOF
EP3654982A4 (en) 1,8-NAPHTHYRIDINONE COMPOUNDS AND THEIR USES
EP3436434A4 (en) INDOLIN ANALOGUES AND USES THEREOF
EP3630113A4 (en) PHARMACEUTICAL COMPOSITION INCLUDING A PDE9 INHIBITOR
EA201990158A1 (ru) Производные бензодиоксана и их фармацевтическое применение
CY1123408T1 (el) Φαρμακευτικες συνθεσεις και χρηση των αυτων
EP3911324A4 (en) 1,8-NAPHTHYRIDINONE COMPOUNDS AND THEIR USES
MA45795A (fr) Composés et compositions, et utilisations associées
EP3611206A4 (en) MONOMER COMPOSITION AND HARDENABLE COMPOSITION THEREFOR
IL282999A (en) 1,3,4-oxadiazolone compound and pharmaceutical